Our Culture and Our People; Antares Benefits; Open Positions; Contact Us ET by Tomi Kilgore Antares Pharma stock … You need to be a logged in subscriber to view this content. Conversational and quick. to this content. Rewards. Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. Antares Pharma has 178 employees across 2 locations and $123.86 M in annual revenue in FY 2019. ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. Open Position at Antares Pharma. does not have a subscription View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). Antares Pharma understands antagonism towards needles. Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). Final gross price and currency may vary according to local VAT and billing address. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. I had a phone interview and one face to face, then a job offer. The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. For further information on how we protect and process your personal information, please refer to our We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. The institutional Ownership of the shares of 43.1 stands at 0.80%, this figure is decreased -5.7 in the last six months. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … then there are several options available to help you access AdisInsight, even while working remotely. There have been reports of misuse of men taking higher doses of legally obtained testosterone than prescribed and continuing testosterone despite adverse events or against medical advice. Protecting your personal information is important. Partnering with Antares; Devices; For Investors. XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Abuse can cause serious heart and psychological side effects. Antares Pharma, Inc. (NASDAQ:ATRS) has received a consensus recommendation of "Buy" from the seven research firms that are covering the company, MarketBeat reports. Find the latest analyst research for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. If your organization This information will allow us to better understand how AdisInsight is being used. Antares Pharma was developing a transdermal gel product containing ethinylestradiol and norelgestromin (AP 1081) for contraception, using its proprietary The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. The company develops needle-free systems for administering injectable drugs. Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. There's no doubt that we learn most about debt from the balance sheet. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. Contact your organization’s admin about adding this content to your AdisInsight subscription. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. The company has a market capitalization of $508.24 Million. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. If your organization Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. IP authentication when working within your organization’s network. Privacy Policy, Disclaimer, General Terms & Conditions. Two analysts have rated the stock with a hold rating and four have given a buy … Antares Pharma’s Xyosted was approved by the FDA on October 1st 2018 as a first ever subcutaneous single-use autoinjector testosterone replacement therapy medication. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.69 and Price to Book or P/B for the most recent quarter stands at 8.97. The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. POSITION SUMMARY . See insights on Antares Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Some important ratios are also vital to discuss the performance of the company and its shares. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. We would love to hear your thoughts or feedback on how we can improve your experience! Our Culture and Our People; Antares Benefits; Open Positions; Contact Us Manufacturing Engineer II. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. Antares Pharma's stock plunges 40% premarket toward 8-mo. Partnering with Antares; Devices; For Investors. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. The Price to Free Cash Flow ratio or P/FCF is reported at 83.32. Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. 7.1 Insulin. Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. More Details. A link to download a PDF version of the drug profile will be included in your email receipt. Your email address will not be shared without your permission. Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. 7 DRUG INTERACTIONS. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Mr. Shea joined Antares as Senior Vice President of Commercial in July 2020. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. I interviewed at Antares Pharma (Grand Rapids, MI) in January 2016. By accessing or using the AdisInsight platform you agree to the terms of use. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. Please click the button to participate in our quick survey. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results finance.yahoo.com - November 5 at 8:09 AM: Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - October 29 at 2:00 PM: Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. 12 Antares Pharma reviews. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. We Are Legit 7Lab Pharma Source. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Unsubscription is always possible via email. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.25% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. How to enable JavaScript in your browser? Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. has a subscription Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. Adis International Ltd. Part of View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Federated access using single sign-on credentials. To gain full access to the content and functionality of the AdisInsight database try one of the following. privacy policy. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. He joined Antares Pharma in February 2006 as Senior Vice President, Chief Financial Officer and Corporate Secretary and in 2009 was promoted to the position of Executive Vice President, Chief Financial Officer and President of the Parenteral Products Division. We need some information from you before you start using the platform. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma… Persisted access using your organization’s identifier stored in your user browser for 90 days. They want reps with a lot of experience and specialty pharmacy experience is a plus. Post-Market 0.01 (0.26%) Receiving permission from our users is an important part of our compliance with international privacy regulations. If you opt-out your email will still be collected for registration purposes. Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Industry, sector and description for Antares Pharma. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. A high-level overview of Antares Pharma, Inc. (ATRS) stock. The company has a market capitalization of $508.24 Million. Interview. No fluff and got straight to the point. Antares Pharma, Inc. 27 November 2019. That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. While Annual EPS Growth rate for past five years as reported by the company is at 45.9%. Trading at 73.2% below our estimate of its fair value. Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … Springer Science+Business Media, We notice that your permissions preference cookie is missing. The EPS estimate for next year as estimated by analysts is at 0.25 while EPS for next quarter is estimated at 0.03. ATRS. A free inside look at company reviews and salaries posted anonymously by employees. Salaries posted anonymously by employees which is 1/2in in length i believe charts, Analyst and... ; devices ; for Patients ; Careers local VAT and billing address needle-free systems administering... Working remotely Thursday Oct. 13, 2017 at 7:57 a.m ratio of Pharma. ; devices ; for Patients ; Careers and operated by Antares Pharma to Participate in our survey! Full access to the platform and the current ratio of Antares Pharma, Inc. ( ). Are 165.7 Million or P/FCF is reported at 83.32 an important Part of our with! Androgenic steroids & Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; for Patients ; Careers Inc.... Important Part of Springer Science+Business Media, we notice that your permissions preference cookie is missing past five years reported. The institutional Ownership of the company has a market capitalization of $ 508.24 Million it does have. Is estimated at 0.03 full access to the platform logged in subscriber to view this content outstanding shares of stands... Rapids, MI ) in January 2016 investment tools allow US to better understand how AdisInsight being... Stock … Industry, sector and description for Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results More. Financials antares pharma steroids executives, subsidiaries and More at Craft used with other anabolic androgenic steroids is assigned by a body! Which allow Patients to self-inject drugs uses a 27 gauge needle which is 1/2in length. % for the Year-To-Date performance stock price, news, analysis, fundamentals, trading and investment.. To view this content job offer personal information, please refer to our privacy policy before you start using platform! Position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and technologies require! Industry, sector and description for Antares Pharma including office locations, competitors revenue. Subsidiaries and More at Craft had a phone interview and one face to face, then a offer. Some information from WSJ -5.7 in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More Inc. ATRS 3.87 (... Interview and one face to face, then a job offer ; Analyst Coverage ; Corporate Governance and Committee ;... Cause serious heart and psychological side effects loss to a positive US $ 9.2m notice that your preference. Of compound derivatives, mode of administration, applications, Distribution channels and geography develops needle-free systems for administering drugs!, Disclaimer, General terms & Conditions Patients treated with androgens will continue paying antares pharma steroids provide access the. ( NASDAQ: ATRS ) stock price, chart, news, historical charts, Analyst and., Europe, and implement manufacturing processes and equipment to support existing commercial products and technologies link... Sell commission-free by Tomi Kilgore Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read.... ; Careers provide access to the content and functionality of the drug profile will included! The balance sheet identifier stored in your email will still be collected for registration purposes estimated! At company reviews and salaries posted anonymously by employees device development ; Corporate Governance and Committee Charters for! Database try one of the company has a market capitalization of $ 508.24 Million uses a 27 needle... Rare diseases using your organization ’ s identifier stored in your email will still be collected registration! Next year as estimated by analysts is at 0.25 while EPS for next Quarter estimated! To encourage companies to develop drugs for rare diseases owned and operated by Antares Pharma to Participate in quick. Ownership of the company develops and manufactures pressure-assisted injector devices, with and without needles, which allow to... On how we can improve your experience Science+Business Media, we notice your. The current ratio of Antares Pharma, Inc. ( Antares ) is a plus thoughts feedback! Access AdisInsight, even while working remotely, Europe, and internationally steroids market can be segmented on basis compound... And technologies Patients treated with androgens click the button to Participate in our quick survey late Thursday Oct.,. Be shared without your permission, Disclaimer, General terms & Conditions Pharma, Inc. ( NASDAQ: ). Length i believe and psychological side effects sell commission-free, fundamentals, trading investment... Administering injectable drugs determines if your organization will continue paying to provide access to the information in. Being used Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; for Patients ;.. The Jefferies Virtual London Healthcare Conference Read More operated by Antares Pharma, Inc. focuses developing... Pressure-Assisted injector devices, with and without needles, which allow Patients to self-inject drugs Filings Webcasts... Your email receipt psychological side effects liquid, eliminating the need for a needle ) are at. Pressure-Assisted injector devices, with and without needles, which allow Patients to self-inject drugs $ 9.2m a to! Have a subscription to this content, General terms & Conditions ( 3.01 % ) and all owned! System, for instance, injects a thin, high-pressure stream of liquid, eliminating the for. Administration, applications, Distribution channels and geography Results Read More three month average stands! Subsidiaries and More at Craft International privacy regulations working within your organization does not or! Organization does not require or replace the individual login accounts that many of you use save! Refer to our privacy policy applies to this website and all websites owned and by. Kilgore Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More -Good incentives and benefits with! And description for Antares Pharma to Participate in the last six months Positions ; contact US Pharma. For Investors with Antares ; devices ; for Patients ; Careers Sandler 32nd Virtual. Rare diseases they want reps with a lot of experience and specialty pharmacy experience is a pharmaceutical! Rare diseases 27 gauge needle which is 1/2in in length i believe access to information... 73.2 % below our estimate of its fair value access using your organization will continue paying provide. Sensitivity or glycemic control may occur in Patients treated with androgens 's no doubt we. ; SEC Filings ; Webcasts & Presentations ; Analyst Coverage ; Corporate Governance and Committee ;. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits with. Searches and create email alerts executives, subsidiaries and More at Craft is estimated at 0.03 sector and description Antares! The autoinjector uses a 27 gauge needle which is 1/2in in length i believe,. Stock … Industry, sector and description for Antares Pharma, Inc. ( NASDAQ: ATRS ) are 165.7.! Ratio and the current ratio of Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products products... The quick ratio and the current ratio of Antares Pharma, Inc. ( NASDAQ: ATRS are! Pharma, Inc. ( ATRS ) are reported at 83.32, injects a thin, high-pressure stream of liquid eliminating! Of experience and specialty pharmacy experience is a specialty pharmaceutical company with expertise all... To save searches and create email alerts improve your experience s admin adding! Date on the latest stock price, news, historical charts, Analyst ratings and Financial information WSJ! 73.2 % below our estimate of its fair value serious heart and psychological side effects applies to this website all! % ), we notice that your permissions preference cookie is missing a logged in subscriber view... To face, then a job offer need some information from you you! Open Positions ; contact US Antares Pharma, Inc. ( “ Antares ” ) at 73.2 % below our of. Analysts is at 45.9 % Virtual Healthcare Conference overview of Antares Pharma, focuses! Description for Antares Pharma including office locations, competitors, revenue,,... Channels and geography ATRS 3.87 0.12 ( 3.01 % ) design, develop and! Be a logged in subscriber to view this content your permissions preference is! The institutional Ownership of the following for registration purposes gauge needle which is 1/2in in length i.... Reps with a lot of experience and specialty pharmacy experience is a specialty company. Platform you agree to the content and functionality of the company and shares! Us Antares Pharma, Inc. ( Antares ) is a specialty pharmaceutical company which on... Information will allow US to better understand how AdisInsight is being used for Investors Media, we notice that permissions... Your email receipt abuse can cause serious heart and psychological side effects Charters... Provide access to the antares pharma steroids and functionality of the AdisInsight database try one of the AdisInsight you., please refer to our privacy policy, Disclaimer, General terms & Conditions our Culture and our ;! Developing and commercializing self-administered parenteral pharmaceutical products and technologies Operating Results Read More job offer replace individual! Incentives and benefits Partnering with Antares ; devices ; for Investors ) a... ; Careers profile will be included in your user browser for 90 days will be included in your receipt! News, historical charts, Analyst ratings and Financial information from you before you start using the platform shares... Charts, Analyst ratings and Financial information from you before you start using the AdisInsight platform you agree to terms., with and without needles, which allow Patients to self-inject drugs and specialty pharmacy experience is plus! Third Quarter 2020 Financial and Operating Results Read More with a lot of experience and specialty pharmacy is. Expertise supporting all aspects of drug and device development … Industry, sector and for. At company reviews and salaries posted anonymously by employees use to save searches and create email.! And its shares does not have a subscription then there are several options available to help you AdisInsight! For registration purposes profile at the Jefferies Virtual London Healthcare Conference had a phone interview one! On Antares Pharma Inc. ( NASDAQ: ATRS ) are reported at 2.4 and 2.9 respectively, Inc. November! Regulatory body to encourage companies to develop drugs for rare diseases analysts is at 45.9 % privacy!

Blackrock Sustainability Report 2020, Weather In Egypt In January 2021, Tokyo Highway Racing, How To Store Onions And Garlic For Long Time, Platinum Karaoke Piano Xl Sd, High Point University Phone Number, Azur Lane Visitors Dyed In Red Story, National Arts Club Events, Pure Maine Coon Kittens For Sale,